Perspective on the Application of Microphysiological Systems to Drug Transporter Studies

被引:11
|
作者
Caetano-Pinto, Pedro [1 ]
Stahl, Simone H. [1 ]
机构
[1] AstraZeneca, IMED Biotech Unit, Mechanist Safety & ADME Sci Drug Safety & Metab, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England
关键词
ON-A-CHIP; KIDNEY PROXIMAL TUBULE; BLOOD-BRAIN-BARRIER; PLURIPOTENT STEM-CELLS; IN-VITRO; SHEAR-STRESS; CULTURE; LIVER; EXPRESSION; MODEL;
D O I
10.1124/dmd.118.082750
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Transmembrane flux of a drug within a tissue or organ frequently involves a complex system of transporters from multiple families that have redundant and overlapping specificities. Current in vitro systems poorly represent physiology, with reduced expression and activity of drug transporter proteins; therefore, novel models that recapitulate the complexity and interplay among various transporters are needed. The development of microphysiological systems that bring simulated physiologic conditions to in vitro cell culture models has enormous potential to better reproduce the morphology and transport activity across several organ models, especially in tissues such as the liver, kidney, intestine, or the blood-brain barrier, in which drug transporters play a key role. The prospect of improving the in vitro function of organ models highly prolific in drug transporters holds the promise of implementing novel tools to study these mechanisms with far more representative biology than before. In this short review, we exemplify recent developments in the characterization of perfused microphysiological systems involving the activity of drug transporters. Furthermore, we analyze the challenges and opportunities for the implementation of such systems in the study of transporter-mediated drug disposition and the generation of clinically relevant physiology-based in silico models incorporating relevant drug transport activity.
引用
收藏
页码:1647 / 1657
页数:11
相关论文
共 50 条
  • [1] Application of Immunocompetent Microphysiological Systems in Drug Development : Current Perspective and Recommendations
    Wang, Xiaoting
    Kopec, Anna K.
    Collinge, Mark
    David, Rhiannon
    Grant, Christian
    Hardwick, Rhiannon N.
    Navratil, Aaron
    Patel, Nirav
    Rowan, Wendy
    Marshall, Nikki B.
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2023, 40 (02) : 314 - 336
  • [2] Cardiovascular microphysiological systems (CVMPS) for safety studies - a pharma perspective
    Pointon, Amy
    Maher, Jonathan
    Davis, Myrtle
    Baker, Thomas
    Cichocki, Joseph
    Ramsden, Diane
    Hale, Christopher
    Kolaja, Kyle L.
    Levesque, Paul
    Sura, Radhakrishna
    Stresser, David M.
    Gintant, Gary
    LAB ON A CHIP, 2021, 21 (03) : 458 - 472
  • [3] Development of intestinal organoids and microphysiological systems and their application to drug discovery
    Iwao, Takahiro
    Matsunaga, Tamihide
    DRUG METABOLISM AND PHARMACOKINETICS, 2025, 60
  • [4] Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery
    Ewart, Lorna
    Dehne, Eva-Maria
    Fabre, Kristin
    Gibbs, Susan
    Hickman, James
    Hornberg, Ellinor
    Ingelman-Sundberg, Magnus
    Jang, Kyung-Jin
    Jones, David R.
    Lauschke, Volker M.
    Marx, Uwe
    Mettetal, Jerome T.
    Pointon, Amy
    Williams, Dominic
    Zimmermann, Wolfram-Hubertus
    Newham, Peter
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58, 2018, 58 : 65 - 82
  • [5] Microphysiological Systems: A Pathologist's Perspective
    Sura, Radhakrishna
    Van Vleet, Terry
    Berridge, Brian R.
    VETERINARY PATHOLOGY, 2020, 57 (03) : 358 - 368
  • [6] Human microphysiological systems for drug development
    Roth, Adrian
    SCIENCE, 2021, 373 (6561) : 1304 - 1306
  • [7] Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review
    Sun, Argus M.
    Hoffman, Tyler
    Luu, Bao Q.
    Ashammakhi, Nureddin
    Li, Song
    BIO-DESIGN AND MANUFACTURING, 2021, 4 (04) : 757 - 775
  • [8] Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review
    Argus M. Sun
    Tyler Hoff man
    Bao Q.Luu
    Nureddin Ashammakhi
    Song Li
    Bio-Design and Manufacturing, 2021, 4 (04) : 757 - 775
  • [9] Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review
    Argus M. Sun
    Tyler Hoffman
    Bao Q. Luu
    Nureddin Ashammakhi
    Song Li
    Bio-Design and Manufacturing, 2021, 4 : 757 - 775
  • [10] Application of microphysiological systems in biopharmaceutical research and development
    Peterson, Norman C.
    Mahalingaiah, Prathap Kumar
    Fullerton, Aaron
    Di Piazza, Matteo
    LAB ON A CHIP, 2020, 20 (04) : 697 - 708